Reported Consolidated quarterly numbers for Chemfab Alkalis are: Net Sales at Rs 81.90 crore in September 2024 up 2.91% from Rs. 79.58 crore in September 2023. Quarterly Net Loss at Rs. 0.53 crore in September 2024 down 112.42% from Rs. 4.30 crore in September 2023. EBITDA stands at Rs. 10.75 crore in September 2024 down 12.88% from Rs. 12.34 crore in September 2023.
Open FlipICICI Securities research report on Blue Jet Healthcare: Blue Jet Healthcare’s (BlueJet) Q2FY25 shows a ramp-up in contrast media as ABA HCL volumes normalise; the segment should see acceleration in growth with the commissioning of intermediate for NCE MRI molecule and iodinated ABA HCL from Q4FY25. BlueJet’s PI/API segment shone bright with higher volumes from cardiovascular molecule.
Open FlipRail Vikas Nigam Limited‘s shares surged on Tuesday after the company emerged as the lowest bidder for a project in South Central railway. What Happened: RVNL on Monday announced it became the lowest bidder for an Engineering, Procurement and Construction (EPC) contract from South Central Railway. The project involves doubling the track between Parbhani to Parli stations in Maharashtra.
Open Flip